Effect of platelet glycoprotein IIb/IIIa receptor inhibition on distal embolization during percutaneous revascularization of aortocoronary saphenous vein grafts

This publication has 15 references indexed in Scilit:

• The Myth of the Myocardial ‘Infarctlet’ During Percutaneous Coronary Revascularization Procedures
  Circulation, 1996
• Predictors and Sequelae of Distal Embolization During Saphenous Vein Graft Intervention From the CAVEAT-II Trial
  Circulation, 1995
• Platelet Glycoprotein IIb/IIIa Receptors in Cardiovascular Medicine
  New England Journal of Medicine, 1995
• A Multicenter, Randomized Trial of Coronary Angioplasty Versus Directional Atherectomy for Patients With Saphenous Vein Bypass Graft Lesions
  Circulation, 1995
• Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months
  The Lancet, 1994
• Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty
  New England Journal of Medicine, 1994
• Comparison of composition of atherosclerotic plaques in saphenous veins used as aortocoronary bypass conduits with plaques in native coronary arteries in the same men
  The American Journal of Cardiology, 1992
• Percutaneous transluminal angioplasty of saphenous vein graft stenosis: long-term follow-up
  Journal of the American College of Cardiology, 1989
• Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.
  Circulation, 1987
• Ruptured atheromatous plaques in saphenous vein coronary artery bypass grafts: a mechanism of acute, thrombotic, late graft occlusion.
  Circulation, 1982